(Q37696265)

22 August 2017

1 reference

title

Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus (English)

1 reference

22 August 2017

0 references

Nikolai Petrovsky

1

0 references

publication date

1 March 2010

1 reference

Nature Reviews Endocrinology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

131-138

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2009.273

22 August 2017

exact match

0 references

cites work

Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Long-term results of early cyclosporin therapy in juvenile IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prospects for the prevention and reversal of type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Vaccine therapies for the prevention of type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Central role of defective apoptosis in autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Infections and autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prevention of type I diabetes in NOD mice by adjuvant immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Effect of adjuvant therapy on development of diabetes in mouse and man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Parasitic worms and inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

The cellular immune response to antigens of Coxiella burneti.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Injection of Inactivated Phase I Coxiella burnetii Increases Non-specific Resistance to Infection and Stimulates Lymphokine Production in Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prevention of autoimmune diabetes through immunostimulation with Q fever complement-fixing antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.273

Q fever: current concepts

31 March 2020

1 reference

12 December 2020

Autoimmune diabetes mellitus in the BB rat

1 reference

12 December 2020

Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice

1 reference

12 December 2020

Breeding of a non-obese, diabetic strain of mice

1 reference

12 December 2020

Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii

1 reference

12 December 2020

Prevention of type I diabetes in nonobese diabetic mice by virus infection

1 reference

12 December 2020

Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Nitric oxide in interstitial nephritis and other autoimmune diseases.

1 reference

12 December 2020

Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae

1 reference

12 December 2020

Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2009.273

1 reference

22 August 2017

1 reference